Oryzon Genomics SA vs Redx Pharma
Redx Pharma
Biotech company focusing on the discovery and development of novel targeted medicines to treat cancer and fibrosis
39 employees · est. 2010 · United Kingdom
Oryzon Genomics SA is the older company (2000 vs 2010); Oryzon Genomics SA is the larger of the two.
Side-by-Side Comparison
| Metric | Oryzon Genomics SA | Redx Pharma |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2010 |
| Headquarters | ||
| Headquarters | Spain | United Kingdom |
| Employees | ||
| Employees | 60 larger | 39 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | Post-IPO Equity |
| Total Funding | ||
| Total Funding | $193.19M | $78.90M |
| Funding Rounds | ||
| Funding Rounds | 21 | 8 |
| Services | ||
| Services | Development of personalized therapeutics, Epigenetic biomarker identification, Innovation in cancer and CNS disorder treatments, Patent portfolio management | Development of novel medicines, Clinical trials and research, Pharmaceutical partnerships, Scientific publications |
| Target Customers | ||
| Target Customers | Patients with cancer, Patients with CNS disorders, Healthcare providers, Biopharmaceutical investors | Medical professionals, Patients with fibrotic diseases, Pharmaceutical partners, Investors in biotechnology |
| Taxonomy | ||
| Taxonomy | Personalized MedicineEpigeneticsCNS DisordersOncologyBiopharmaceuticalsLSD1 Inhibitors +9 | Drug DiscoveryClinical StageSmall Molecule TherapeuticsCancer TreatmentFibrotic DiseasesROCK2 Inhibitor +8 |
| Website | ||
| Website | oryzon.com | redxpharma.com |
About Oryzon Genomics SA
Oryzon Genomics SA, founded in 2000 and headquartered in Spain, is a clinical stage biopharmaceutical leader in the development of epigenetics-based therapeutics, with an emphasis on personalized medicine for CNS disorders and oncology. Known for its slogan, "Pioneering personalized medicine in epig...
About Redx Pharma
Founded in 2010, Redx Pharma is a clinical-stage biotechnology company headquartered in the United Kingdom. The company is dedicated to the discovery and development of novel, small molecule, targeted therapeutics for treating cancer and fibrotic diseases. Its strength lies in its team of world-clas...
Also comparing in this category
Comparing more than these two?
Get Oryzon Genomics SA, Redx Pharma and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Oryzon Genomics SA compare?
A PDF of Oryzon Genomics SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Oryzon Genomics SA with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Oryzon Genomics SA on 26 Mar 2026, and Redx Pharma on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
